Effect Of GW501516X On How The Heart Obtains And Uses Energy
The purpose of this study is to determine the effect of a 4-week treatment period with GW501516X on how the heart obtains and uses energy. The energy of the heart will be measured by Magnetic Resonance Imaging (MRI). This study will also measure a number of other potential markers of drug activity, including levels of certain lipids (fats) and proteins in your blood. The data from this study may help researchers better understand the actions of this drug in the body and if this drug may be useful to treat patients with heart disease.
|Official Title:||A Two Part Study to Separately Evaluate the Effect of 4-week Treatment With GW501516X Relative to Placebo on Cardiac Energetics in a Randomized, Single-blind, Repeat Dose, Parallel Group Design in Healthy Male Subjects|
- Energy-related chemicals and heart contraction, determined by MRI measurement of the heart.
- Additional energy-related chemicals, determined by MRI measurement of the heart. Blood proteins. Safety of GW501516X.
|Study Start Date:||December 2005|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00318617
|United States, Pennsylvania|
|GSK Investigational Site|
|Philadelphia, Pennsylvania, United States, 19104|
|Study Director:||GSK Clinical Trials||GlaxoSmithKline|